What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Eckhard Thiel spends much of his time researching Internal medicine, Immunology, Surgery, Leukemia and Oncology.
Eckhard Thiel regularly links together related areas like Gastroenterology in his Internal medicine studies.
Immunology is frequently linked to Transplantation in his study.
His Transplantation study deals with Virology intersecting with Acquired immunodeficiency syndrome.
The various areas that Eckhard Thiel examines in his Leukemia study include Myeloid, Cancer research, Myeloid leukemia and Haematopoiesis.
His Oncology research includes themes of Lymphoblastic Leukemia, Anemia, White blood cell, Survival analysis and Bone marrow.
His most cited work include:
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis (2622 citations)
- Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation (1329 citations)
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis (718 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Immunology, Cancer research, Oncology and Surgery.
Much of his study explores Internal medicine relationship to Gastroenterology.
As part of his studies on Immunology, Eckhard Thiel frequently links adjacent subjects like Cytotoxic T cell.
His study in Oncology is interdisciplinary in nature, drawing from both Cancer and Melanoma.
His Chemotherapy study combines topics in areas such as Methotrexate and Radiation therapy.
His Leukemia research is multidisciplinary, incorporating elements of Myeloid, Myeloid leukemia and Immunophenotyping.
He most often published in these fields:
- Internal medicine (36.31%)
- Immunology (32.56%)
- Cancer research (17.29%)
What were the highlights of his more recent work (between 2008-2017)?
- Internal medicine (36.31%)
- Immunology (32.56%)
- Oncology (16.28%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Immunology, Oncology, Transplantation and Surgery.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
His Immunology research is multidisciplinary, relying on both Cytotoxic T cell and BAALC.
His work deals with themes such as Cancer, Bioinformatics, Pathology, ThioTEPA and Survival analysis, which intersect with Oncology.
His research integrates issues of Immunosuppression, Stem cell and Virology in his study of Transplantation.
His work on Ifosfamide, Radiation therapy and Survival rate as part of his general Surgery study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Between 2008 and 2017, his most popular works were:
- Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation (1329 citations)
- Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. (523 citations)
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial (392 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Eckhard Thiel mainly focuses on Internal medicine, Immunology, Transplantation, Leukemia and Oncology.
His biological study spans a wide range of topics, including Gastroenterology and Surgery.
His studies link Peripheral blood mononuclear cell with Immunology.
His Transplantation research incorporates elements of Stem cell, Immunopathology and Virology.
His work carried out in the field of Leukemia brings together such families of science as Cancer research, Myeloid leukemia and Fms-Like Tyrosine Kinase 3.
His Oncology research integrates issues from Randomized controlled trial, Multimodal therapy and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
